Factor Xa inhibitors also showed a significantly lower risk of intracranial bleeding (RR = .40, 95% CI = .17–.96, p = .04), but no significant differences were evident for other outcomes, including gastrointestinal bleeding, hemorrhagic stroke, ischaemic stroke, acute coronary syndrome and mortality.102. This evidence concerns the gene F10 and hemorrhagic stroke.